Fotemustine in patients with advanced gastric cancer, a phase II trial from the EORTC-CITCCG (European organization for research and treatment of cancer, gastrointestinal tract cancer cooperative group)

European Journal of Cancer Part A

Volumn 32, Issue 8, 1996, Pages 1432-1433

  Rougier, Ph ^a   Van Pottelsberghe, C ^b   Kok, T ^b   Paillot, B ^b   Wagener, T ^b   De Greve, J ^b   Fabri, M C ^b   Gerard, B ^a   Van Glabbeke, M ^b   Bleiberg, H ^b  

^a INSTITUT GUSTAVE ROUSSY   (France)

^b NONE

Author keywords

Fotemustine; Gastric cancer; Phase II trial

Indexed keywords

FOTEMUSTINE;

ADULT; ADVANCED CANCER; ARTICLE; BLEEDING; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; NEUTROPENIA; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; STOMACH CANCER; THROMBOCYTOPENIA;

EID: 0030017734     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/0959-8049(96)00088-3     Document Type: Article

References (9)

1. Wils J, Bleiberg H. Perspectives in cancer research. Current status of chemotherapy for gastric cancer. Eur J Cancer Clin Oncol 1989, 25, 3-8.
2. Comis RL, Carter SK. Review of chemotherapy in gastric cancer. Cancer 1974, 34, 1576-1586.
3. Khayat D, Lokiec F, Bizzari JP, et al. Phase I clinical study of the new amino acid-linked nitrosourea, S 10036 administered on a weekly schedule. Cancer Res 1987, 47, 6782-6785.
4. Jacquillat C, Khayat D, Banzet P, et al. Final report of the French multicenter phase II study of the nitrosourea Fotemustine in 153 evaluable patients with disseminated malignant melanoma including patients with cerebral metastases. Cancer 1990, 66, 1873-1878.
5. Miller AB, Hoogstratten B, Staquet M, et al. Reporting results of cancer treatment. Cancer 1981, 47, 2507-2514.
6. Wils J, Klein H, Wagener DJT, et al. Sequential high-dose methotrexate and fluorouracil combined with doxorubicin. A step ahead in the treatment of advanced gastric cancer. A trial of the European Organization for Research and Treatment of Cancer Gastrointestinal Tract Cooperative Group. J Clin Oncol 1991, 9, 827-831.
7. Bun PA, Nugent JL, Ihde DC, et al. 5-Fluorouracil, Methyl-CCNU, Adriamycin, and Mitomycin C in the treatment of advanced gastric cancer. Cancer Treat Rep 1978, 62, 1287-1293.
8. Buroker T, Kim PN, Groppe C, et al. 5 FU infusion with Mitomycin C vs 5 FU infusion with methyl-CCNU in the treatment of advanced upper gastrointestinal cancer. A Southwest Oncology Group Study. Cancer 1979, 44, 1215-1221.
9. Rougier P, Chabot GG, Bonneterre J, et al. Phase II and pharmacokinetic study of fotemustine in inoperable colorectal cancer. Eur J Cancer 1993, 29A, 288-289.